论文部分内容阅读
1药物治疗进展1·1血管紧张素转换酶抑制剂与血管紧张素Ⅱ受体拮抗剂血管紧张素转换酶抑制剂(ACEI)的临床应用被认为是充血性心力衰竭治疗中最重要的进展之一,已成为治疗心力衰竭(HF)的基石。部分难治性心力衰竭(RHF)患者因出现干咳等症状而不能耐受ACEI,可改用血管紧张素Ⅱ受
1 drug treatment progress 1.1 angiotensin converting enzyme inhibitors and angiotensin Ⅱ receptor antagonist angiotensin converting enzyme inhibitor (ACEI) clinical application is considered to be the most important progress in the treatment of congestive heart failure First, it has become the cornerstone of treatment of heart failure (HF). Some patients with refractory heart failure (RHF) due to dry cough and other symptoms can not tolerate ACEI, can be used angiotensin Ⅱ